Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Cancer Research|October 11, 2018
LPA4-Mediated Vascular Network Formation Increases the Efficacy of Anti-PD-1 Therapy against Brain TumorsDaisuke Eino, Yohei Tsukada, Hisamichi Naito, et al.
Journal of Neuro-Oncology|November 18, 2011
Clinical characteristics of meningiomas assessed by ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron-emission tomographyHideyuki Arita, Manabu Kinoshita, Yoshiko Okita, et al.
Journal of Neurointerventional Surgery|March 16, 2021
Efficacy of endovascular intratumoral embolization for meningioma: assessment using dynamic susceptibility contrast-enhanced perfusion-weighted imagingKatsunori Asai, Hajime Nakamura, Yoshiyuki Watanabe, et al.
Cancer Immunology, Immunotherapy : CII|November 16, 2018
A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant gliomaAkihiro Tsuboi, Naoya Hashimoto, Fumihiro Fujiki, et al.
World Neurosurgery|November 21, 2024
Ophthalmic Artery Feeders in Meningioma Reduce the Effectiveness of Transarterial Embolization With n-Butyl CyanoacrylateTomofumi Takenaka, Takeo Nishida, Masatoshi Takagaki, et al.
Journal of Neuro-Oncology|February 1, 2019
MicroRNA regulating stanniocalcin-1 is a metastasis and dissemination promoting factor in glioblastomaJunichi Sakata, Takashi Sasayama, Kazuhiro Tanaka, et al.
Plos One|January 10, 2025
Cerebral blood flow and histological analysis for the accurate differentiation of infiltrating tumor and vasogenic edema in glioblastomaHideki Kuroda, Yoshiko Okita, Atsuko Arisawa, et al.
Cancer Immunology, Immunotherapy : CII|March 6, 2025
Prostaglandin F2 receptor negative regulator as a potential target for chimeric antigen receptor-T cell therapy for glioblastomaHideki Kuroda, Noriyuki Kijima, Tetsuro Tachi, et al.
Surgical Case Reports|March 16, 2022
Successful separation of male pygopagus with anal canal and urethral reconstruction: a case reportChiyoshi Toyama, Motonari Nomura, Yuko Tazuke, et al.
BMC Cancer|April 7, 2020
PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphomaMotomasa Furuse, Hiroko Kuwabara, Naokado Ikeda, et al.
Pageof 11